Insider trade

Thermo Fisher Scientific (TMO): Executive Vice President sold ~$164K

Gianluca Pettiti, Executive Vice President at Thermo Fisher Scientific, sold ~$164K of Thermo Fisher Scientific shares.

~$164K
Approx. value · 400 sh @ $411.11
23K
Holds after · shares reported
Traded
May 12, 2025
Filed
May 13, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 11, 2024CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  2. Feb 25, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  3. Mar 3, 2025Congress · 1 personMembers of Congress: 2 purchases
  4. Mar 27, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  5. Apr 7, 2025Congress · 2 peopleMembers of Congress: 2 sales
  6. Apr 8, 2025Congress · 2 peopleMembers of Congress: 2 sales
  7. Apr 11, 2025Congress · 2 peopleMembers of Congress: 2 sales
  8. Apr 15, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Moxifloxacin in the dilution range of 0.008-16 ug/mL
  9. Apr 21, 2025Congress · 1 personMembers of Congress: 2 sales
  10. Apr 28, 2025InsiderOfficer sold ~$129K of TMO shares in the open market
  11. Apr 29, 2025Layoff notice · 100 West Gore Street, ORLANDO, FL, 32806Layoff notice filed in FL: 59 employees
  12. May 5, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  13. May 12, 2025 · this disclosureInsiderOfficer sold ~$164K of TMO shares in the open market

What came next

  1. May 13, 2025CongressDisclosed purchase of TMO — reported range $15,001 - $50,000
  2. May 15, 2025CongressDisclosed purchase of TMO — reported range $15,001 - $50,000
  3. May 16, 2025CongressDisclosed sale of TMO — reported range $15,001 - $50,000
  4. May 22, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Vancomycin in the dilution range of 0.25-128 ug/mL
  5. Jun 10, 2025CongressDisclosed partial sale of TMO — reported range $1,001 - $15,000
  6. Jun 12, 2025FDAFDA device clearance: Thermo Scientific Oxoid Aztreonam/Avibactam Disc (30/20 µg) AZA50
  7. Jun 20, 2025FDAFDA device clearance: The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Ceftobiprole in the dilution range…
  8. Jun 30, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mL
  9. Jul 2, 2025FDAFDA device approval: Oncomine Dx Express Test
  10. Jul 21, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  11. Jul 22, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  12. Jul 25, 2025InsiderOfficer sold ~$192K of TMO shares in the open market
  13. Jul 29, 2025Layoff notice · 5823 Newton Dr Carlsbad CA 92008Layoff notice filed in CA: 52 employees
  14. Jul 29, 2025Layoff notice · 5781 Van Allen Way Carlsbad CA 92008Layoff notice filed in CA: 33 employees
  15. Aug 6, 2025Insider · 1 personInsiders: 15 sales (~$4.5M)
  16. Aug 7, 2025Insider · 1 personInsiders: 5 sales (~$3.6M)
  17. Aug 19, 2025InsiderCEO sold ~$101K of TMO shares in the open market
  18. Aug 20, 2025Insider · 1 personInsiders: 2 sales (~$148K)
  19. Aug 22, 2025Insider · 1 personInsiders: 3 sales (~$5.0M)
  20. Aug 28, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mL
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Thermo Fisher Scientific

For Thermo Fisher Scientific, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 6 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMO page.

Other recent filings by Gianluca Pettiti, Executive Vice President

The full history of Gianluca Pettiti, Executive Vice President is on the profile page.

How this filing works

Explore the data

Common questions

Which Thermo Fisher Scientific (TMO) insider traded, and how much?

Gianluca Pettiti, Executive Vice President at Thermo Fisher Scientific, sold ~$164K of Thermo Fisher Scientific shares. 400 shares at $411.11.

When did it happen, and when was it made public?

Traded: May 12, 2025. Filed: May 13, 2025. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Thermo Fisher Scientific recently?

For Thermo Fisher Scientific, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 6 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days. They are listed on the TMO page.

Does this mean TMO stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Thermo Fisher Scientific

Everything OQRO holds on this company is on its TMO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data